Curated Resources — Prognosis and treatment of Reglan-related Tardive Dyskinesia

Below is a working bibliography of trusted health, pharmacovigilance, and legal-analysis sources, compiled for open research.

In-depth resource

Prognosis and treatment of Reglan-related Tardive Dyskinesia: Key Facts & Context

A focused review of background, context, and source material on this subject.

European Medicines Agency (EMA)

Reference: European Medicines Agency (EMA)

Authoritative source for clinical, regulatory, and public-health background reading.

Mayo Clinic — Diseases & Conditions

Reference: Mayo Clinic — Diseases & Conditions

Authoritative source for clinical, regulatory, and public-health background reading.